MLNT News and Press, Melinta Therapeutics Inc - Ordinary Shares From 05/09/19

Melinta Therapeutics (NASDAQ: MLNT ): Q1 GAAP EPS of -$2.34 beats by $2.67 . More news on: Melinta Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

~ Revenue of $14.1 million, Including Net Product Sales of $11.8 million, for the First Quarter 2019 ~ ~ Reduction of Operating Expenses of 34 Percent, or $19.8 million, Year-Over-Year ~ ~ Filed Supplemental New Drug Application for Baxdela ® (delafloxacin)  for th...

MORRISTOWN, N.J., May 07, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial infections, announced today that it will present data on its portfolio, i...

MORRISTOWN, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial infections, today announced it intends to release its first quarter 2019 ...

Antibiotic resistance is a growing global public health emergency. Melinta Therapeutics ( MLNT ) has decided to take up the critical mission of overcoming antibiotic resistance with their broad spectrum antibiotic portfolio. Unfortunately, the market doesn’t see the opportunity in addre...

WASHINGTON , April 12, 2019 /PRNewswire/ -- The Antimicrobials Working Group (AWG), a coalition of companies with the mission to combat drug-resistant infections and spur life-saving innovations, today announced that twelve of its member companies will present data from their clinica...

April 9, 2019 Palm Beach, FL –April 9, 2019 – Medical technology is an area where the U.S. companies are at the forefront. In fact, according to recent industry publication the: “U.S. remains the largest medical device market in the world, with a market size of aro...

Gainers: Nordic American Offshore (NYSE: NAO ) +33%.  Melinta Therapeutics (NASDAQ: MLNT ) +23% . New Age Beverages (NASDAQ: NBEV ) +21% . Celldex Therapeutics (NASDAQ: CLDX ) +18% . Reliv International (NASDAQ: RELV ) +18% . Niu Technologies (NASDAQ: NIU ) +18% . Laredo Petrol...

MORRISTOWN, N.J., April 08, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial infections, today announced that researchers are scheduled to present m...

Atossa Genetics (NASDAQ: ATOS ) +223%  on expanded access for Endoxifen. More news on: Atossa Genetics Inc., Hancock Jaffe Laboratories, Inc., Safe-T Group Ltd, Stocks on the move, Read more ...